Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Donald Trump
Research
HHS reverses course, won’t end women’s health study contracts
Days after the long-running Women's Health Initiative announced HHS was terminating some of its contracts, the agency said it will restore funding.
Darren Incorvaia
Apr 25, 2025 11:48am
Boston Scientific plans to make ground despite tariff headwinds
Apr 24, 2025 12:15pm
Tariffs make M&A decisions 'more difficult,' says Roche CEO
Apr 24, 2025 4:40am
Intuitive posts strong 1Q earnings as tariffs squeeze margins
Apr 23, 2025 11:00am
Harvard sues Trump admin over threats to freeze research funds
Apr 22, 2025 10:54am
NIH bans grant recipients from promoting DEI, boycotting Israel
Apr 21, 2025 6:00pm